SBHMY

SINO BIOPHARM UNSP/ADR by Sino Biopharmaceutical Ltd. (SBHMY)

About SINO BIOPHARM UNSP/ADR by Sino Biopharmaceutical Ltd. (SBHMY)

Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Investment, Modernised Chinese Medicines and Chemical Medicines; and Others. The Investment segment offers long-term investments. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products. The Investment segment offers long-term investments. The Other segment includes a research and development sector, which provides services to third parties; and related healthcare and hospital business. It also develops medicines for treating tumors, analgesia, diabetes, and respiratory system diseases. The company was founded by Ping Tse Cheung Ling Cheng and on February 2, 2000, and is headquartered in Hong Kong.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$10.30
52 Week Low
$6.69
Market cap
8.7B
Dividend yield
1.63%
Volume
--
Avg. volume
93
P/E ratio
35.27

SINO BIOPHARM UNSP/ADR by Sino Biopharmaceutical Ltd. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$10.30
52 Week Low
$6.69
Market cap
8.7B
Dividend yield
1.63%
Volume
--
Avg. volume
93
P/E ratio
35.27